Testing naldemedine for constipation caused by opioid pain meds
Part of Mental health clinical trials.
This study tests whether naldemedine is safe and how the body processes it in children who take opioid medicines and are dealing with constipation or are at risk for it. It may help some children by reducing constipation side effects from opioid pain treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer or non-cancer pain and you are taking opioids now or about to start them
- You have constipation that is new, or a past history of constipation treated with laxatives, or constipation is expected after opioids
- You (or your child) can stay at the clinic for blood draws for at least 12 hours after the first dose, and return at 24 hours
- Child’s growth is within a healthy range for age (BMI roughly the 3rd to 97th percentiles)
- You do not have a recent or planned surgery in the gut (within the last year for past surgery, or upcoming surgery)
- You do not have signs of a blocked or perforation-risk gut (for example, obstruction) and can eat or swallow normally
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether naldemedine, a medication for constipation, can help cancer patients who have constipation caused by opioids. It looks at how well it works and how patients feel.
This study looks at how well naldemedine (and certain other constipation medicines) lower the risk of major heart problems in people who take opioids for constipation. It compares medicine use patterns in people with opioid-induced constipation to see who has fewer serious heart events.
This trial tests a sustained-release tablet (oxycodone/naloxone) for cancer patients with severe pain and constipation caused by opioids. It aims to see how well the drug works in real-world conditions.
This study tests whether starting a bowel-prevention approach can help stop constipation caused by opioid pain medicines in people with advanced (metastatic) cancer. You may be able to join if you are about to start long-acting or skin opioid pain treatment.
This study tests a traditional Chinese medicine treatment for constipation caused by opioid pain medications in cancer patients. The goal is to help people on long-term opioid therapy have more regular bowel movements without increasing laxative use.
This study tests a combination of two medicines to see how well it works for sedation during a painless endoscopy (a tube test of the stomach) in people with obesity. It aims to find the best dose for safer and more comfortable procedures.
Hear when a new Opioid-Induced Constipation (OIC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.